Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding-Reference-Cited by-同舟云学术

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding

Published:2012-10-04 Issue:3 Volume:83 Page:155-160
ISSN:1445-1433
Container-title:ANZ Journal of Surgery
language:en
Short-container-title:ANZ J Surg

Author:

Kandane-Rathnayake Rangi K.¹,Isbister James P.²,Zatta Amanda J.¹,Aoki Naomi J.¹,Cameron Peter,Phillips Louise E.¹,

Affiliation:

1. Department of Epidemiology and Preventive Medicine; School of Public Health and Preventive Medicine; Monash University; Melbourne; Victoria; Australia

2. Transfusion Medicine; Royal North Shore Hospital; Sydney; New South Wales; Australia

Publisher

Wiley

Subject

General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-2197.2012.06285.x/fullpdf

Reference34 articles.

1. The contemporary approach to the care of Jehovah's Witnesses;Hughes;J. Trauma,2008

2. Blood transfusion and Jehovah's Witnesses: the legal and ethical issues;McInroy;Br. J. Nurs.,2005

3. Uncontrolled bleeding in surgical patients: the role of recombinant activated factor VIIa;Phillips;Curr. Drug Targets,2009

4. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register;Isbister;Intern. Med. J.,2008

5. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry;Phillips;Anesth. Analg.,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced bloodless clinical procedures proven in practice;Anesteziologie a intenzivní medicína;2024-03-28

2. Bloodless Management of the Anemic Patient in the Emergency Department;Annals of Emergency Medicine;2022-01

3. Pharmacotherapy in Acutely Anemic Jehovah’s Witnesses: An Evidence-Based Review;Annals of Pharmacotherapy;2018-03-28